Indian pharma stocks faced selling pressure on February 19 after Trump announced potential tariffs on pharmaceutical imports.

Burmans' open offer for acquiring an additional 26% stake in Religare Enterprises Ltd. received a weak response, with only ...

The Burman family's open offer of Rs 2,116 crore to acquire an additional 26 percent stake in Religare Enterprises Ltd (REL) resulted in only a 0.07 percent response. Allegations of insider trading ...

The Nifty SmallCap index surged 2.70 per cent, or 410.7 points, to hit an intraday high of 15,579.15. Similarly, the Nifty ...

At 9:25 AM, the Sensex was down 193 points or 0.3 percent at 75,803, and the Nifty was down 73 points or 0.3 percent at ...

After an 18-month struggle, the Burman family's open offer for Religare has concluded and Rashmi Saluja is out of the way.

From the financial basket, Bajaj Finance has ended the prolonged correction phase after spending nearly 3 years in a range. Traders can buy for a target of Rs 9800 in the next 2-4 months,” Ajit Mishra ...

Last month, when Florida-based investor Digvijay ‘Danny’ Gaekwad approached the Securities and Exchange Board of India (Sebi) ...

Unabated foreign fund outflows, lower-than-expected quarterly earnings and global trade war fears hit market sentiments last ...

In this week's newsletter, also read about Ameera Shah, executive chairperson of Metropolis Healthcare's views on gender ...

The applicant (Danny Gaekwad Developments & Investments, Florida) has failed to demonstrate his ability to meet the financial ...

Sebi has rejected Digvijay Gaekwad's application to make a competing offer for Religare Enterprises, citing insufficient ...